Author response for 'Proposed rituximab biosimilar BCD‐020 versus reference rituximab for treatment of patients with indolent non‐Hodgkin lymphomas: an international multicenter randomized trial'

Autor:	null Irina V. Poddubnaya, null Sergey M. Alekseev, null Kamil D. Kaplanov, null Les M. Lukavetskyy, null Grigoriy B. Rekhtman, null Tuphan K. Dolai, null V. Satya Suresh Attili, null Carlos D. Bermúdez, null Aleksandr A. Isaev, null Ekaterina V. Chernyaeva, null Roman A. Ivanov
Rok vydání:	2019
DOI:	10.1002/hon.2693/v3/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::94d067c37bb3655c0ac8d9092a28e8e3 https://doi.org/10.1002/hon.2693/v3/response1 Zobrazit plný text záznamu